Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
DARE Dare Bioscience Inc
- Stocks
- Healthcare
- NASDAQ: DARE
Price (delayed)
$2.88
Market cap
$25.49M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.48
Enterprise value
$11.08M
Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. The company's mission is to identify, develop and bring to market a diverse
Highlights
DARE's EPS has surged by 88% year-on-year and by 14% since the previous quarter
The debt has declined by 7% year-on-year and by 7% since the previous quarter
DARE's net income has surged by 87% year-on-year but it is down by 12% since the previous quarter
The company's quick ratio rose by 21% YoY but it fell by 20% QoQ
The company's gross profit has shrunk by 100% YoY and by 99% QoQ
DARE's revenue has shrunk by 100% YoY and by 99% QoQ
Key stats
What are the main financial stats of DARE
Market
Valuations
Earnings
Shares outstanding
8.85M
Market cap
$25.49M
Enterprise value
$11.08M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
2,501.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1,132.66
Revenue
$9,784
Gross profit
$9,784
Operating income
-$23.45M
Net income
-$4.05M
EBIT
-$4.05M
EBITDA
-$4.01M
Free cash flow
$4.82M
Per share
Balance sheet
Liquidity
EPS
-$0.48
EPS diluted
-$0.48
Free cash flow per share
$0.57
Book value per share
-$0.69
Revenue per share
$0
TBVPS
$2.6
Total assets
$22.1M
Total liabilities
$28.11M
Debt
$1.3M
Equity
-$6.01M
Working capital
-$3.16M
Debt to equity
-0.22
Current ratio
0.85
Quick ratio
0.74
Net debt/EBITDA
3.59
Margins
Efficiency
Dividend
EBITDA margin
-40,998.3%
Gross margin
100%
Net margin
-41,430.9%
Operating margin
-239,692.2%
Return on assets
-21.1%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-823.7%
Return on sales
-41,430.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
DARE stock price
How has the Dare Bioscience stock price performed over time
Intraday
-1.03%
1 week
-4.64%
1 month
-2.04%
1 year
-22.79%
YTD
-7.69%
QTD
-0.35%
Financial performance
How have Dare Bioscience's revenue and profit performed over time
Revenue
$9,784
Gross profit
$9,784
Operating income
-$23.45M
Net income
-$4.05M
Gross margin
100%
Net margin
-41,430.9%
The company's gross profit has shrunk by 100% YoY and by 99% QoQ
DARE's revenue has shrunk by 100% YoY and by 99% QoQ
DARE's net income has surged by 87% year-on-year but it is down by 12% since the previous quarter
The company's operating income rose by 24% YoY
Price vs fundamentals
How does DARE's price correlate with its fundamentals
Growth
What is Dare Bioscience's growth rate over time
Valuation
What is Dare Bioscience stock price valuation
P/E
N/A
P/B
N/A
P/S
2,501.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1,132.66
DARE's EPS has surged by 88% year-on-year and by 14% since the previous quarter
The equity has contracted by 19% YoY
DARE's revenue has shrunk by 100% YoY and by 99% QoQ
Efficiency
How efficient is Dare Bioscience business performance
The ROA has soared by 83% YoY but it has contracted by 11% from the previous quarter
Dividends
What is DARE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for DARE.
Financial health
How did Dare Bioscience financials performed over time
The total assets is 21% less than the total liabilities
The total liabilities has grown by 44% from the previous quarter and by 7% YoY
The current ratio has contracted by 25% from the previous quarter
The debt is 122% greater than the equity
The debt to equity has soared by 77% from the previous quarter and by 21% YoY
The equity has contracted by 19% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.